University Health Network and Boehringer Ingelheim Canada partner to impact patients lives and help a healthcare system under strain

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

The Ontario healthcare system is under strain, still recovering from the demands of the COVID-19 pandemic. The University Health Network (UHN) and Boehringer Ingelheim (Canada) Ltd. have partnered to address a critical need of heart failure patients.

The objective of the partnership is to expand patient reach of UHN’s successful Medly Program— an innovative, digital therapeutic solution that delivers the benefits of specialized clinical heart failure management at home while improving quality of life and reducing hospitalizations.

Medly presented at the 2022 OBIO® Investment Summit as part of the Early Technology Showcase.

Arsheen Kaur
Previous

Congratulations to OBIO® members and affiliated companies on receiving funding from INOVAIT and Government of Canada
Next

MEMOTEXT and CAMH Awarded Funding from OBIO’s Early Adopter Health Network to Trial Automated Mental Health Texting Check-in, Support & Navigation Tool